Trial no.:
|
PACTR201505001142202 |
Date of Approval:
|
15/05/2015 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Metformin and weight gain in the obese with pregnancy |
Official scientific title |
Can metformin limit weight gain in the obese with pregnancy? |
Brief summary describing the background
and objectives of the trial
|
Maternal overweight and obesity is associated with many obstetric complications. Obesity is linked to insulin resistance. Improving insulin sensitivity may therefore account for weight reduction. Metformin is a bigaunide that decreases hepatic glucose output by inhibiting gluconeogenesis and enhancing peripheral glucose uptake. It also decreases intestinal glucose absorption and increases insulin sensitivity. It was found to be effective in type 2 diabetes and polycystic ovarian syndrome through improving insulin sensitivity. Several studies proved its efficacy in the obese non- pregnants , but its role during pregnancy is not yet well-established.
Objectives: we are testing the ability of metformin to limit weight gain and pregnancy complications namely gestational Diabetes and hypertension in the obese with pregnancy.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Nutritional, Metabolic, Endocrine,Obese pregnant women,Pregnancy and Childbirth |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Prevention |
Anticipated trial start date |
01/08/2014 |
Actual trial start date |
01/08/2014 |
Anticipated date of last follow up |
31/03/2015 |
Actual Last follow-up date |
31/03/2015 |
Anticipated target sample size (number of participants) |
200 |
Actual target sample size (number of participants) |
200 |
Recruitment status |
Completed |
Publication URL |
|
|